Back
Janux Therapeutics Stock Price Chart
Sell
36
JANX
Janux Therapeutics
Last Price:
47.49
Seasonality Move:
8.69%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
Janux Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.16 | Sell |
| 20-day SMA: | 53.14 | Sell |
| 50-day SMA: | 45.73 | Buy |
| 200-day SMA: | 19.83 | Buy |
| 8-day EMA: | 51.46 | Sell |
| 20-day EMA: | 51.69 | Sell |
| 50-day EMA: | 44.87 | Buy |
| 200-day EMA: | 26.12 | Buy |
Janux Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.65 | Buy |
| Relative Strength Index (14 RSI): | 44.8 | Sell |
| Chaikin Money Flow: | -816878 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.28 - 57.98) | Sell |
| Bollinger Bands (100): | (11.51 - 48.73) | Buy |
Janux Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 47.48 while JANX 8-day simple moving average is 53.16, which is a Sell signal.
- The stock price of JANX is 47.48 while Janux Therapeutics 20-day SMA is 53.14, which makes it a Sell.
- Janux Therapeutics 50-day simple moving average is 45.73 while JANX share price is 47.48, making it a Buy technically.
- JANX stock price is 47.48 and Janux Therapeutics 200-day simple moving average is 19.83, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
36
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Sell
The current Janux Therapeutics [JANX] share price is $47.48. The Score for JANX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
2.46B
Price in USD:
47.48
Share Volume:
918.53K
Janux Therapeutics 52-Week Range
52-Week High:
65.60
52-Week Low:
5.65
Sell
36
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?
The Janux Therapeutics stock price is 47.48 USD today. -
Will JANX stock go up or go down?
Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Janux Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 47.48 while JANX 8-day exponential moving average is 51.46, which is a Sell signal.
- The stock price of JANX is 47.48 while Janux Therapeutics 20-day EMA is 51.69, which makes it a Sell.
- Janux Therapeutics 50-day exponential moving average is 44.87 while JANX share price is 47.48, making it a Buy technically.
- JANX stock price is 47.48 and Janux Therapeutics 200-day simple moving average is 26.12, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
- JANX Moving Average Covergence Divergence (MACD) indicator is 1.65, suggesting Janux Therapeutics is a Buy
- Janux Therapeutics Relative Strength Index (RSI) is 44.8, which suggest Janux Therapeutics is oversold
- The Bollinger Bands (25) for Janux Therapeutics is (47.28 - 57.98), which suggest Janux Therapeutics is a Buy
- The Bollinger Bands (100) for Janux Therapeutics is (11.51 - 48.73), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.